QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CTEV

QT77Claritev Corporation
NYSE·Healthcare·Medical - Healthcare Information Services·USA
Latest market price
29.42
-0.33-1.11%
OverviewShort InterestFilings
CTEVQT77Claritev Corporation·NYSE
OverviewShort InterestFilings
29.42-1.11%
TA
Loading chart...
Screen all →
GEHC+0.72%$61.59VEEV-1.00%$153.30BTSG+2.82%$66.25TEM+4.20%$50.84HQY-1.30%$85.21HNGE+3.55%$69.42TXG+8.19%$34.76DOCS+0.05%$20.46
Snapshot
Index-P/E-EPS (ttm)
-17.33
Insider Own23.63%
Shs Outstand17.05M
Perf Week-8.15%
Market Cap507.17MForward P/E-EPS next Y-13.97Insider Trans0.57%Shs Float-Perf Month81.60%
Enterprise Value5.09BPEG-EPS next Q-4.10Inst Own-Short Float-Perf Quarter91.79%
Income-292638084.00P/S0.52EPS this Y7.58%Inst Trans-Short Ratio-Perf Half Y-23.29%
Sales978.76MP/B-EPS next Y12.76%ROA-5.92%Short Interest-Perf YTD-31.18%
Book/sh-13.72P/C5.03EPS next 5Y-ROE205.84%52W High74.07 -60.28%Perf Year-26.87%
Cash/sh1.23P/FCF-EPS past 3/5Y-ROIC0.78%52W Low11.50 155.83%Perf 3Y-
Dividend Est.-EV/EBITDA9.85Sales past 3/5Y-3.68% 0.57%Gross Margin61.06%Volatility6.54% 7.55%Perf 5Y-
Dividend TTM-EV/Sales5.21EPS Y/Y TTM87.21%Oper. Margin4.29%ATR (14)2.82Perf 10Y-
Dividend Ex-Date-Quick Ratio1.28Sales Y/Y TTM5.26%Profit Margin-29.27%RSI (14)57.49Recom2.20
Dividend Gr. 3/5Y-Current Ratio1.28EPS Q/Q-28.57%SMA208.31%Beta2.31Target Price39.25
Payout0.00%Debt/Eq-19.11Sales Q/Q6.06%SMA5021.75%Rel Volume1.24Prev Close29.75
Employees2,700LT Debt/Eq-27.62EarningsAug 05SMA200-17.08%Avg Volume146.06KPrice29.42
IPO DateApr 03, 2020Option/ShortYes / YesEPS/Sales Surpr.-15.75% 3.81%Net Debt/EBITDA8.87Volume180,830Change-1.11%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-03-26ReiteratedPiper SandlerOverweight$90 → $61
Apr-24-26InitiatedBarclaysOverweight$28
Feb-24-26ReiteratedGuggenheimBuy$38
Feb-24-26ReiteratedWells FargoEqual Weight$33 → $30
Jan-08-26InitiatedWells FargoEqual Weight$33
Oct-22-25UpgradeCitigroupNeutral → Buy
Oct-21-25UpgradeCitigroupNeutral → Buy
May-29-25UpgradePiper SandlerNeutral → Overweight
Latest News
Jun-17-26
Jun-17-2601:35PM
7 Health Care Stocks With Whale Alerts In Today's SessionBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue980965931
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A381699239
Gross Profit599267691
Selling, General and Administrative Excl. Other207222160
Research and Development
000
Other Operating Expense34901,921
Operating Income4345-1,390
Interest Expense398400326
Unusual Expense
———
Non-Operating Income (Expense)-271854
Net Income Before Taxes-329-373-1,771
Income Taxes-41-89-125
Consolidated Net Income-288-284-1,646
Net Income From Continuing Operations-288-284-1,646
Net Income-288-284-1,646
EPS (Recurring)-17.33-17.30-101.92
EPS (Basic, Before Extraordinaries)-17.33-17.30-101.92
EPS (Diluted)-17.33-17.30-101.92
EBITDA518475-1,008
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio0.510.71—
Gross Margin61.1227.6774.22
Operating Margin4.394.66-149.30
Net Margin-29.39-29.43-176.80
Shares Outstanding171616
Market Capitalization500684—
Operating Lease Expense
———
Insider Trading Volume
$32.72$29.25$25.77$22.30$18.83● Close Price0.00M18.25M36.50M54.75M73.00MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Carol NutterSVP, Chief People OfficerJun 09 '26Buy28.4187524,85646,941Jun 10 12:00 AM
Prince John MichaelDirectorMay 19 '26Buy16.0010,000160,00031,662May 19 12:00 AM
Dalton TravisPres., CEO & Executive ChairMay 18 '26Buy12.3620,920258,63845,872May 19 12:00 AM
Kim MichaelEVP, Chief Digital OfficerMay 18 '26Buy16.653,00049,950185,878May 19 12:00 AM
Garis Douglas MichaelEVP&CFOMar 16 '26Buy17.691,30022,997206,152Mar 16 12:00 AM
Kim MichaelEVP, Chief Digital OfficerMar 12 '26Buy16.5015,000247,500182,878Mar 16 12:00 AM
O'Neil TaraSVP, General CounselMar 02 '26Buy12.997509,74327,199Mar 02 12:00 AM
Dalton TravisPres., CEO & Executive ChairFeb 27 '26Buy13.0015,380199,92824,952Mar 02 12:00 AM
Kim MichaelEVP, Chief Digital OfficerFeb 27 '26Buy14.3030,000428,955137,973Mar 02 12:00 AM
Dalton TravisPres., CEO & Executive ChairNov 20 '25Buy47.235,290249,8429,572Nov 20 12:00 AM
Mintz William B.SVP, Chief Strategy OfficerNov 17 '25Buy38.0091634,80865,325Nov 19 12:00 AM
Kim MichaelEVP, Chief Digital OfficerNov 17 '25Buy38.259,600367,199105,529Nov 18 12:00 AM
O'Neil TaraSVP, General CounselNov 17 '25Buy38.8462524,27325,028Nov 18 12:00 AM
H&F Corporate Investors VIII, Ltd.10% OwnerNov 12 '25Sale48.671,500,00073,001,2498,932Nov 14 12:00 AM
Dalton TravisPres., CEO & Executive ChairAug 11 '25Buy58.303,982232,1584,282Aug 12 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR